Primary Dysmenorrhea – Global API Manufacturers, Marketed and Phase III Drugs Landscape 2016 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets (
has announced the addition of the “Primary
Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2016”
report to their offering.

Primary Dysmenorrhea – Global API Manufacturers, Marketed and Phase III
Drugs Landscape, 2016, provides comprehensive insights about the
marketed drugs, drug sales, Phase III pipeline drugs and their API
Manufacturers across the globe.

A key objective of the Primary Dysmenorrhea Report is to understand the
market and pipeline status of the drugs around the Primary Dysmenorrhea
to explore the generic development opportunities, licensing
opportunities and to gain competitive advantage on designing pipeline
strategies. The Report provides the historical and forecasted sales of
the drugs till 2018.

The Report gives insights into patents providing the patent protection
data and marketing exclusivity of all the drugs across the Primary
Dysmenorrhea. While the leading brands, companies and chemicals are
considered thoroughly, the report also provides details on the Global
API Manufacturers across the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Primary Dysmenorrhea

7. Phase III Drugs for Primary Dysmenorrhea

8. Discontinued Drugs for Primary Dysmenorrhea

9. Appendix

For more information visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women’s